Phase 3 Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older, of any gender
- People who have a confirmed or suspected diagnosis of glioblastoma (a type of brain tumour)
- People who are already scheduled to have standard surgery to remove a brain tumour or take a small tissue sample (biopsy)
- People whose most recent brain scan (MRI) shows a measurable area of the tumour greater than 1ml that lights up with contrast dye
Who may not be able to join:
- People who have a condition or abnormality that the trial investigator believes could affect their safety or the reliability of the trial data
- People who are unable to tolerate an MRI scan, or who have a medical reason they cannot have a specific type of MRI that uses a 3-Tesla (3T) machine
- People who have any medical reason that would make it unsafe to receive an iron-oxide nanoparticle-based contrast agent (a special dye used during imaging) — medical records will be reviewed by a qualified doctor to assess this (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Mean diffusion-relaxation correlation spectrum imaging (DR-CSI) value; Ferumoxytol-enhanced magnetic resonance imaging (Fe-MRI) measures; Chemical exchange saturation transfer (CEST) values
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.